Summary
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. 
The global Liposome Drug Delivery market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Liposomal Bupivacaine
Other Liposomals
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Company Coverage (Sales data, Main Products & Services etc.):
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Teva Pharmaceutical
Ipsen (Onivyde)
Fudan-Zhangjiang
CSPC
Novartis
Kingond Pharm
Shanghai New Asia
Spectrum Pharmaceuticals
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa

Table of Content
1 Industry Overview
1.1 Liposome Drug Delivery Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Liposome Drug Delivery Market by Type
2.1 By Type
2.1.1 Liposomal Doxorubicin
2.1.2 Liposomal Amphoteracin B
2.1.3 Liposomal Paclitaxel
2.1.4 Liposomal Bupivacaine
2.1.5 Other Liposomals
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Fungal Infection Therapy
3.1.2 Cancer & Tumor Therapy
3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Johnson & Johnson (Company Profile, Sales Data etc.)
5.2 Gilead Sciences (Company Profile, Sales Data etc.)
5.3 Pacira (Company Profile, Sales Data etc.)
5.4 Sun Pharmaceutical (Company Profile, Sales Data etc.)
5.5 Luye Pharma (Company Profile, Sales Data etc.)
5.6 Sigma-Tau Group (Company Profile, Sales Data etc.)
5.7 Teva Pharmaceutical (Company Profile, Sales Data etc.)
5.8 Ipsen (Onivyde) (Company Profile, Sales Data etc.)
5.9 Fudan-Zhangjiang (Company Profile, Sales Data etc.)
5.10 CSPC (Company Profile, Sales Data etc.)
5.11 Novartis (Company Profile, Sales Data etc.)
5.12 Kingond Pharm (Company Profile, Sales Data etc.)
5.13 Shanghai New Asia (Company Profile, Sales Data etc.)
5.14 Spectrum Pharmaceuticals (Company Profile, Sales Data etc.)
6 Conclusion